chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives / urticaria appeared on approximately 11/15 with no known cause and despite using hypoallergenic soaps, lotions, etc. It is ongoing and managed by daily Claritin and nightly Benadryl, as well as anti-itch cream and topical lidocaine.   I was exposed to Covid on a daily basis while my young children were sick after 11/12/21 through the end of Thanksgiving but remained negative on five subsequent tests (both PCR and rapid).  I suspect based on the occurrence of this same issue of chronic hives post booster that it was a delayed reaction from the vaccine.
The day after the patient had the Varicella vaccine she developed painful red rash with blistering to (R) upper arm around site of injection. Seen at Urgent Care for treatment on 6/9/14 - started on clindamycin. Dx. with "cellulitis".
Patient had received two prior doses of Pfizer COVID vaccine.   That series was completed back in January.  Patient is fine with no symptoms.
Chest pain and shortness of  breath 2 days after 2nd vaccine.  Presented to ED and found to have elevated troponin.
throwing up rapidly multiple times; dry heaving because my body kept wanting to throw up; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 12:15 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unknown birth control medication from an unknown date taken within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 02:00 the patient experienced throwing up rapidly multiple times until there was nothing left in stomach, then the patient was dry heaving because the body kept wanting to throw up. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events.  Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events throwing up, dry heaving were recovered on 15Apr2021.   No follow-up attempts are needed. No further information is expected.
About 30 minutes post vaccination patient complained of headache and palpitations and was hypertensive. VS were taken and she was given water but symptoms did not resolve
Maculopapular erythematous rash to bilat upper and lower extremities, trunk and neck.
After the 1st dose, which she got in her left arm, she had a roaring case of Covid arm that lasted for 6 days, cleared up, then came back for 6 days again; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (After the 1st dose, which she got in her left arm, she had a roaring case of Covid arm that lasted for 6 days, cleared up, then came back for 6 days again) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (After the 1st dose, which she got in her left arm, she had a roaring case of Covid arm that lasted for 6 days, cleared up, then came back for 6 days again). At the time of the report, VACCINATION SITE REACTION (After the 1st dose, which she got in her left arm, she had a roaring case of Covid arm that lasted for 6 days, cleared up, then came back for 6 days again) outcome was unknown.            No concomitant medication were provided. No treatment medication were provided.   This case was linked to MOD-2022-600694, MOD-2022-600693.
Soreness on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness on the arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Lisinopril). Concomitant products included HYDROCHLOROTHIAZIDE (HCTZ) for Blood pressure.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness on the arm). At the time of the report, PAIN IN EXTREMITY (Soreness on the arm) outcome was unknown.            Treatment: Steroids  were taken for her pain on the right knee the brand is Kenolog.   This case was linked to MOD-2022-462888, MOD-2022-462971 (Patient Link).
Vaccine given on 01-25-2021. Wife reported on 01-29-2021 that patient had a ran a fever on 01-26-2021, Was better on 01-27-2021. She found him dead when she came home work on the evening of 01-28-2021.
Significantly sore at injection site; flu-like symptons (achy and sore and no energy) the day after being vaccinated.
Aches; Fever; Headache; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: EN6198), via an unspecified route of administration, administered in the right arm on 25Feb2021 13:00 (at the age of 52-years-old) as dose 2, single for COVID-19 immunization. Medical history included high blood pressure (BP) and sulfa allergy. Concomitant medications included sambucus nigra fruit (ELDERBERRY), lisinopril, ascorbic acid (VIT C), and ergocalciferol (VIT D). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318) via an unspecified route of administration, administered in the left arm in Feb2021 13:00 (at the age of 52-years-old) for COVID-19 immunization, and experienced soreness in arm. The patient did not receive any other vaccine within four weeks of the COVID vaccination. Prior to vaccination, the patient had no history of COVID-19. on 25Feb2021 16:00, the patient experienced headache. On 26Feb2021, the patient woke up with fever (100.2), with aches and headache. The patient was able to work and then went to bed early. On 27Feb2021, the patient woke up to fever of 99.9, but felt well enough to go about her day. The fever was gone by afternoon. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were not taken as result of the events. The outcome of event fever was recovered on 27Feb2021 while the outcome of the remaining events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.
First notice on 3/1/21. Red rash, on bicep size of a band aid. 1 inch wide by 3 inches long. 3/10/21, 2 inches wide by 3 inches long.  No discomfort, no itching, no tenderness.
Received vaccine (R) deltoid at approximately 1:30 pm -> by 5 pm the same day noticed redness, swelling, pain. No itching. Pt used ice to area and took ADVIL.
Developed a fever about 5 hrs after BOOSTRIX which climbed to 104 & slowly came down over the next 5 days. Also c/o ringing of ears & muffled hearing, chills, back pain, nausea, dizziness, headache, swollen, painful injection site, & cough.
5/8/2021 I was driving down the interstate and felt as if someone put an iv with contrast into my left arm (same arm I received the vaccine).  This whole side of my body went numb, tingling and felt like it was on fire.  My chest was tight and I felt awful.    Since this date I continue to experince the following.  All of the symptoms come and go and severity changes: -Left leg and foot will go numb and tingling -Right leg and foot will go numb and tingling -I have falled on two occassions because my leg feels like it is completely gone -Left wrist and hand will go numb and tingling -Right wrist and hand will go numb and tingling -Sometimes i cannot type or apply makeup because my hands won't work -Face will go numb and tingling -Sleeping too much -Unable to sleep due to pain -Pain in joints and muscles impacted by the numbess and tingling -Heavy chest (feels like someone is squeezing the chest area) -Increased headaches/migraines -Leak urine when I sneeze or cough (has also never happened before)  There has not been any changes in my personal life or work life.
My son was given his MMR vaccine to his Left thigh  on 10-17-06. Developed a small area at injection site red and raised after the injection with grew to almost his whole thigh in two days. Day 3 back to the doctors office and saw DR the spot starting to go down. Dr advised me that my son had a reaction to the MMR-when it comes time we may think about not giving the second injection. Day 5 my son started having suddle head jerks which have now developed into myoclonic seizures. He now has physical therapy and will have to start speech therapy due to these seizures.  MMR 1 Merk 6/08 Lot 0707F Pub date1/03 Left leg IM, Prevnar Wyeth 1/08 B08649F Pub dat 12/98 Right leg SQ 05/23/07-records received-EEG report 1/24/07-abnormal because of drowsiness and sleep related frontal, central vertex, polyspike and spike wave discharges. No clinical accompaniment was seen with these. This tracing suggestive of the lowered threshold for generalized seizures. 1/4/09 Myclonic, Atoni, Toni-Clonic, seizures multpile daily. 60 day Follow-up Information 07-JUL-2007: Myoclonic seizures.
Rash is red; Rash is red itchy, swollen, warm to touch, feel like like it's pulling; Rash is red itchy; Rash is red itchy, swollen; Quarter size rash at the injection site; Pain at site of injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Rash is red) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), COLECALCIFEROL (VITAMIN D3), POTASSIUM and ATENOLOL for an unknown indication.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Rash is red) (seriousness criterion medically significant), SKIN WARM (Rash is red itchy, swollen, warm to touch, feel like like it's pulling), RASH PRURITIC (Rash is red itchy), VACCINATION SITE SWELLING (Rash is red itchy, swollen), VACCINATION SITE RASH (Quarter size rash at the injection site) and VACCINATION SITE PAIN (Pain at site of injection). The patient was treated with PREDNISONE at an unspecified dose and frequency and LORATADINE (CLARITINE) at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Rash is red), SKIN WARM (Rash is red itchy, swollen, warm to touch, feel like like it's pulling), RASH PRURITIC (Rash is red itchy), VACCINATION SITE SWELLING (Rash is red itchy, swollen), VACCINATION SITE RASH (Quarter size rash at the injection site) and VACCINATION SITE PAIN (Pain at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Severe sore throat and esophagitis. Treatment: amoxicillin. Outcome: currently ongoing, unknown.
Dizziness and headache, 2 hours after flu shot until now, fluids, same.
Patient received Meningococcal Polysaccharide A, C, Y, W-135 TT Conjugate vaccine but due to the multifunction of the syringe and needle we don't know how much of the dose the patient received. Vaccine leaked out from the syringe during administration. Per PCP, the patient is recommended to receive a second dose.  Manufacturer was called after incident and they stated that 76.9% of patient that did receive a second dose did not have a reaction to the vaccine and the 30 % that reported a reaction was  fever, pain and redness at the sight of the injection. Patient will be scheduled to receive a second dose.
extreme Weakness; had a Fall; He was unable to help himself up; This case was reported by a consumer via call center representative and described the occurrence of weakness in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th January 2021, the patient received the 1st dose of Shingrix (intramuscular). On 5th February 2021, 10 days after receiving Shingrix, the patient experienced weakness, fall and activities of daily living impaired. On an unknown date, the outcome of the weakness, fall and activities of daily living impaired were recovering/resolving.   It was unknown if the reporter considered the weakness, fall and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The reporter was patient's wife. The patient had extreme weakness, he also had a fall and was unable to help himself up. The reporter got him up. The patient's symptoms were beginning to improve at the time of reporting. All information was not available. The repoter consented to follow-up. This case had been linked with US2021030891, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021030891:same reporter
none  covid 19 vaccine expired 11/22/2022 Given : 12/12/2022
3cm circular erythema patch on right deltoid, warm to touch. Minimal induration & minimal tenderness to palpation.
chills; fever; my left arm is so swollen; severe pain; huge lump on the injection site and still swollen; huge lump on the injection site and still swollen; This is a spontaneous report from a contactable Other Health Care Professional (HCP) (Patient). A 45-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL8982, Expiration date was not reported), via an unspecified route of administration, in arm left, on 06Feb2021 at 13:00 (at the age of 45-year-old), as a single dose for covid-19 immunization. The patient medical history included high blood pressure. Concomitant medications included zinc and boswellia serrata resin, colecalciferol, collagen (OSTEO BI-FLEX EASE). Historical vaccine included the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL8982, Expiration date was not reported), via an unspecified route of administration, in left arm, on 16Jan2021 at 12:00 (at the age of 45-year-old), as a single dose for covid-19 immunization. The patient had no known allergies. The patient had no covid prior vaccination. The patient had not tested post vaccination. Facility type vaccine was reported as Nursing Home/Senior Living Facility. There was no other vaccine received in four weeks. On 07Feb2021 at 15:00, on the second dose the patient had chills, fever and my left arm is so swollen with severe pain. She stated that now its Wednesday and I received the shot on Saturday. There is a huge lump on the injection site and still swollen with a huge bump. There was no treatment received for adverse events. Outcome of the events huge lump on the injection site and still swollen was reported as not recovered and chills, fever, swollen arm, pain was reported as recovering.  Follow-up attempts completed. No further information expected.
49 yo female received 1st dose Pfizer vaccine on 8/12/21. When client arrived at vaccine site, client reported to Lead RN that 30 hours after receiving the Pfizer vaccine she experienced a severe burning sensation that she described as a "sun burn" as well as nerve pain in arms and legs lasting for several hours. Client stated the pain still continues to come back in waves, particularly burning in the palms of hands and soles of feet. Client followed up with PCP 2 weeks after receiving vaccine and PCP referred to Neurologist. Client received diagnostic testing with Neurologist and reported neurologist told her everything came back normal. Client took gabapentin one time to treat pain but did not continue due to severe dizziness. Client reported she experienced a similar burning sensation in March 2020 when she tested positive for COVID-19. Client has NKDA and no chronic health conditions. Client provided Dr. note advising she receives Janssen vaccine for 2nd dose. Lead nurse elevated request to vaccine RN supervisor. RN supervisor elevated request to  MD. MD gave clearance for client to receive Janssen as 2nd dose with a 30 minute observation. Client received the Janssen COVID-19 vaccine (lot#1822809, expiration 03/07/22) in the L deltoid at approximately 1600. No adverse reaction observed during 30 minute observation. Advised client to follow up with PCP and reviewed ER precautions.
left arm injection site started having a reaction; red pimple; it is the size of a lima bean and very painful; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (left arm injection site started having a reaction), ACNE (red pimple) and VACCINATION SITE PAIN (it is the size of a lima bean and very painful) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (left arm injection site started having a reaction), ACNE (red pimple) and VACCINATION SITE PAIN (it is the size of a lima bean and very painful). At the time of the report, VACCINATION SITE REACTION (left arm injection site started having a reaction), ACNE (red pimple) and VACCINATION SITE PAIN (it is the size of a lima bean and very painful) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. Patient received First Primary monovalent dose on 26-MAR-2021, Lot number- 007B21A. Second Primary monovalent dose on 23-APR-2021 Lot number- 006C21A. First Monovalent Booster dose on 14-DEC-2021 Lot number- 060H21A.  No treatment medication details was reported.
Tingling at injection site, nauseous and did not eat breakfast. 108/62, HR 72, O2Sat 99% 9:30am Patient left at 9:30am, stated that she is feeling better.
This spontaneous report was received from a pharmacist refers to unspecified patients of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On unspecified dates, the patients were vaccinated with GARDASIL 9 (lot #, expiry date, dose, dose number, vaccination site, route unspecified). The vaccines were exposed to a temperature of 33 Fahrenheit (F) for 1 hour and 57 F for 1 hour. No previous temperature excursions were reported. Product quality complaint (PQC) was not involved. No adverse effects were reported. Digital data logger was not involved. No additional information was provided. This is one of three reports received from the same reporter. Additional information is not expected because the reporter refused to contact further.
general malaise and sore arm on March 16th.  Wednesday felt better but not perfect.  March 18th got up with headache, nausea and dizziness.
mild discomfort; chills; feverish condition 100.5; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (mild discomfort), CHILLS (chills) and PYREXIA (feverish condition 100.5) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (mild discomfort), CHILLS (chills) and PYREXIA (feverish condition 100.5). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DISCOMFORT (mild discomfort) and CHILLS (chills) outcome was unknown and PYREXIA (feverish condition 100.5) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: 100.5 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown.            Concomitant medications were not reported.  Treatment details were not reported.  Patient took second dose on 31-MAR-2021 in the left arm.
Short-term memory loss that presented just days after the Moderna Covid-19 vaccination. Symptoms became even worse after second vaccination on February 20, 2021. Short-term memory loss still persists.
GFR go way down; blood in their  urine; This spontaneous case was reported by an other health care professional and describes the occurrence of GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine). At the time of the report, GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glomerular filtration rate: low (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Patient presented to pharmacy multiple times after vaccination complaining of soreness in arm that made movement difficult.  Soreness did not resolve and has affected quality of life.